BLM and myelodysplastic syndrome: In their case-control study, Broberg et al. investigated 26 tagged single nucleotide polymorphisms (tagSNPs) in RMI1, TOP3A, and BLM and their associations with AML/myelodysplastic syndromes, malignant melanoma cancer, breast cancer, and bladder cancer risk.